Surgical menopause enhances hippocampal amyloidogenesis following global cerebral ischemia

Journal of Sport and Health Science

Volumn 3, Issue 3, 2014, Pages 206-216

  Scott, Erin L ^a   Zhang, Quan Guang ^a   Dong, Yan ^a   Han, Dong ^a   Wang, Rui Min ^a   Vadlamudi, Ratna K ^b   Brann, Darrell W ^a  

^a AUGUSTA UNIVERSITY   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Amyloid; Dementia; Estrogen; Ischemia; Surgical menopause

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN; BETA SECRETASE 1; ESTRADIOL; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GLOBAL BRAIN ISCHEMIA; HIPPOCAMPAL AMYLOIDOGENESIS; HIPPOCAMPAL CA1 REGION; MENOPAUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; YOUNG ADULT;

EID: 84906244921     PISSN: 20952546     EISSN: 22132961     Source Type: Journal    
DOI: 10.1016/j.jshs.2014.04.003     Document Type: Article

References (57)

1. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69:1074-1083.
2. Rivera C.M., Grossardt B.R., Rhodes D.J., Rocca W.A. Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology 2009, 33:32-40.
3. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011, 1379:188-198.
4. Zhang Q.G., Wang R.M., Scott E., Han D., Dong Y., Tu J.Y., et al. Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause. Brain 2013, 136(Pt 5):1432-1445.
5. Ramirez-Bermudez J. Alzheimer's disease: critical notes on the history of a medical concept. Arch Med Res 2012, 43:595-599.
6. Defina P.A., Moser R.S., Glenn M., Lichtenstein J.D., Fellus J. Alzheimer's disease clinical and research update for health care practitioners. J Aging Res 2013, 2013:207178.
7. Zheng H., Koo E.H. Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener 2011, 6:27. 10.1186/1750-1326-6-27.
8. Willnow T.E., Petersen C.M., Nykjaer A. VPS10P-domain receptors - regulators of neuronal viability and function. Nat Rev Neurosci 2008, 9:899-909.
9. De Strooper B., Vassar R., Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 2010, 6:99-107.
10. Pike C.J., Carroll J.C., Rosario E.R., Barron A.M. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 2009, 30:239-258.
11. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000, 101:485-512.
12. Brann D.W., Dhandapani K., Wakade C., Mahesh V.B., Khan M.M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007, 72:381-405.
13. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996, 156:2213-2217.
14. Fox M., Berzuini C., Knapp L.A. Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women. Psychoneuroendocrinology 2013, 38:2973-2982.
15. Simpkins J.W., Wen Y., Perez E., Yang S., Wang X. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology. Ann N Y Acad Sci 2005, 1052:233-242.
16. Zhang Q.G., Wang R., Khan M., Mahesh V., Brann D.W. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci 2008, 28:8430-8441.
17. Shah R.D., Anderson K.L., Rapoport M., Ferreira A. Estrogen-induced changes in the microtubular system correlate with a decreased susceptibility of aging neurons to beta amyloid neurotoxicity. Mol Cell Neurosci 2003, 24:503-516.
18. Marin R., Ramirez C., Morales A., Gonzalez M., Alonso R., Diaz M. Modulation of Abeta-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts. Steroids 2008, 73:992-996.
19. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A 2005, 102:19198-19203.
20. Li R., He P., Cui J., Staufenbiel M., Harada N., Shen Y. Brain endogenous estrogen levels determine responses to estrogen replacement therapy via regulation of BACE1 and NEP in female Alzheimer's transgenic mice. Mol Neurobiol 2013, 47:857-867.
21. Jayaraman A., Carroll J.C., Morgan T.E., Lin S., Zhao L., Arimoto J.M., et al. 17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology 2012, 153:5467-5479.
22. Liang K., Yang L., Yin C., Xiao Z., Zhang J., Liu Y., et al. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J Biol Chem 2010, 285:935-942.
23. Xiao Z.M., Sun L., Liu Y.M., Zhang J.J., Huang J. Estrogen regulation of the neprilysin gene through a hormone-responsive element. J Mol Neurosci 2009, 39:22-26.
24. Huang J., Guan H., Booze R.M., Eckman C.B., Hersh L.B. Estrogen regulates neprilysin activity in rat brain. Neurosci Lett 2004, 367:85-87.
25. Sambamurti K., Kinsey R., Maloney B., Ge Y.W., Lahiri D.K. Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J 2004, 18:1034-1036.
26. Nord L.C., Sundqvist J., Andersson E., Fried G. Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells. Neurodegener Dis 2010, 7:349-364.
27. Zhang X., Wang J., Xing Y., Gong L., Li H., Wu Z., et al. Effects of ginsenoside Rg1 or 17beta-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease. Neuroscience 2012, 220:191-200.
28. Anukulthanakorn K., Malaivijitnond S., Kitahashi T., Jaroenporn S., Parhar I. Molecular events during the induction of neurodegeneration and memory loss in estrogen-deficient rats. Gen Comp Endocrinol 2013, 181:316-323.
29. Fernandez J.W., Rezai-Zadeh K., Obregon D., Tan J. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS Lett 2010, 584:4259-4267.
30. Sun M., Zhou T., Zhou L., Chen Q., Yu Y., Yang H., et al. Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sAbetaPPalpha. J Alzheimers Dis 2012, 28:795-808.
31. Nadadur R.D., Umar S., Wong G., Eghbali M., Iorga A., Matori H., et al. Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension. J Appl Physiol (1985) 2012, 113:149-158.
32. Zhang Q.G., Tian H., Li H.C., Zhang G.Y. Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus. Neurosci Lett 2006, 408:159-164.
33. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979, 10:267-272.
34. Pulsinelli W.A., Buchan A.M. The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke 1988, 19:913-914.
35. Wen Y., Yang S., Liu R., Simpkins J.W. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res 2004, 1022:30-38.
36. Wen Y., Yang S., Liu R., Brun-Zinkernagel A.M., Koulen P., Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem 2004, 279:22684-22692.
37. Wen Y., Yang S.H., Liu R., Perez E.J., Brun-Zinkernagel A.M., Koulen P., et al. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 2007, 1772:473-483.
38. Pluta R., Jablonski M., Ulamek-Koziol M., Kocki J., Brzozowska J., Januszewski S., et al. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes. Mol Neurobiol 2013, 48:500-515.
39. Epis R., Marcello E., Gardoni F., Vastagh C., Malinverno M., Balducci C., et al. Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain 2010, 133:3323-3335.
40. Schroeder A., Fahrenholz F., Schmitt U. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease. J Alzheimers Dis 2009, 16:309-314.
41. Gil-Bea F., Akterin S., Persson T., Mateos L., Sandebring A., Avila-Carino J., et al. Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain. EMBO Mol Med 2012, 4:1097-1111.
42. Pietri M., Dakowski C., Hannaoui S., Alleaume-Butaux A., Hernandez-Rapp J., Ragagnin A., et al. PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med 2013, 19:1124-1131.
43. Marshall A.J., Rattray M., Vaughan P.F. Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels. Brain Res 2006, 1099:18-24.
44. Lee P.H., Hwang E.M., Hong H.S., Boo J.H., Mook-Jung I., Huh K. Effect of ischemic neuronal insults on amyloid precursor protein processing. Neurochem Res 2006, 31:821-827.
45. Auerbach I.D., Vinters H.V. Effects of anoxia and hypoxia on amyloid precursor protein processing in cerebral microvascular smooth muscle cells. J Neuropathol Exp Neurol 2006, 65:610-620.
46. Zhang S.Q., Sawmiller D., Li S., Rezai-Zadeh K., Hou H., Zhou S., et al. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation. PLoS One 2013, 8:e71913. 10.1371/journal.pone.0071913.
47. Cardenas A., Moro M.A., Leza J.C., O'Shea E., Davalos A., Castillo J., et al. Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cereb Blood Flow Metab 2002, 22:1297-1302.
48. Pradillo J.M., Romera C., Hurtado O., Cardenas A., Moro M.A., Leza J.C., et al. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab 2005, 25:193-203.
49. Zhang Q.G., Han D., Wang R.M., Dong Y., Yang F., Vadlamudi R.K., et al. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc Natl Acad Sci U S A 2011, 108:E617-E624.
50. Zhang Q.G., Raz L., Wang R., Han D., De Sevilla L., Yang F., et al. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci 2009, 29:13823-13836.
51. Li R., Shen Y., Yang L.B., Lue L.F., Finch C., Rogers J. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J Neurochem 2000, 75:1447-1454.
52. Hamilton R.T., Rettberg J.R., Mao Z., To J., Zhao L., Appt S.E., et al. Hippocampal responsiveness to 17beta-estradiol and equol after long-term ovariectomy: implication for a therapeutic window of opportunity. Brain Res 2011, 1379:11-22.
53. Ding F., Yao J., Zhao L., Mao Z., Chen S., Brinton R.D. Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS One 2013, 8:e59825. 10.1371/journal.pone.0059825.
54. Bohacek J., Daniel J.M. The beneficial effects of estradiol on attentional processes are dependent on timing of treatment initiation following ovariectomy in middle-aged rats. Psychoneuroendocrinology 2010, 35:694-705.
55. Raz L., Zhang Q.G., Han D., Dong Y., De Sevilla L., Brann D.W. Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen. PLoS One 2011, 6:e27039. 10.1371/journal.pone.0027039.
56. Scott E.L., Zhang Q.G., Han D., Desai B.N., Brann D.W. Long-term estrogen deprivation leads to elevation of Dickkopf-1 and dysregulation of Wnt/beta-Catenin signaling in hippocampal CA1 neurons. Steroids 2013, 78:624-632.
57. Suzuki S., Brown C.M., Dela Cruz C.D., Yang E., Bridwell D.A., Wise P.M. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci U S A 2007, 104:6013-6018.